Pediatrix Medical Group Inc (NYSE: MD) stock fell -1.10% on Monday to $9.00 against a previous-day closing price of $9.10. With 0.64 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.55 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $9.24 whereas the lowest price it dropped to was $8.97. The 52-week range on MD shows that it touched its highest point at $17.30 and its lowest point at $8.58 during that stretch. It currently has a 1-year price target of $10.83. Beta for the stock currently stands at 1.62.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MD was down-trending over the past week, with a drop of -1.64%, but this was down by -28.68% over a month. Three-month performance dropped to -39.11% while six-month performance fell -34.78%. The stock lost -42.27% in the past year, while it has lost -39.43% so far this year. A look at the trailing 12-month EPS for MD yields 1.13 with Next year EPS estimates of 1.31. For the next quarter, that number is 0.33. This implies an EPS growth rate of -24.68% for this year and 4.68% for next year. EPS is expected to decline by -4.58% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -25.56%.
Float and Shares Shorts:
At present, 82.95 million MD shares are outstanding with a float of 82.14 million shares on hand for trading. On Oct 30, 2023, short shares totaled 3.27 million, which was 3.89% higher than short shares on Sep 28, 2023. In addition to Dr. James D. Swift M.D. as the firm’s CEO & Director, Mr. C. Marc Richards serves as its Executive VP & CFO.
Through their ownership of 105.03% of MD’s outstanding shares, institutional investors have majority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MD since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With MD analysts setting a high price target of $12.00 and a low target of $9.00, the average target price over the next 12 months is $10.83.
Summary of Insider Activity:
Insiders traded MD stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 13 while that of sell transactions has risen to 15 over the past year. The total number of shares bought during that period was 332,284 while 220,813 shares were sold.